Aggrastat



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Angina Unstable 24.0%
Acute Myocardial Infarction 13.9%
Acute Coronary Syndrome 13.6%
Coronary Angioplasty 13.2%
Cerebrovascular Accident 8.8%
Myocardial Infarction 7.3%
Cardiac Enzymes Increased 4.4%
Drug Use For Unknown Indication 2.5%
Angina Pectoris 1.6%
Electrocardiogram St Segment Depression 1.6%
Cerebral Thrombosis 1.3%
Prophylaxis 1.3%
Antiplatelet Therapy 0.9%
Coronary Artery Disease 0.9%
Diabetes Mellitus 0.9%
Electrocardiogram St Segment Elevation 0.9%
Product Used For Unknown Indication 0.9%
Arteriogram Coronary 0.6%
Arteriosclerosis 0.6%
Cardiovascular Event Prophylaxis 0.6%
Thrombocytopenia 31.5%
Myocardial Infarction 17.9%
Death 7.7%
Cerebral Haemorrhage 4.8%
Cardiogenic Shock 4.2%
Ventricular Fibrillation 4.2%
Haemorrhage 3.6%
Shock Haemorrhagic 3.0%
Thrombosis In Device 3.0%
Post Procedural Complication 2.4%
Troponin T Increased 2.4%
White Blood Cell Count Increased 2.4%
Gastrointestinal Haemorrhage 1.8%
Haematoma 1.8%
Haematuria 1.8%
Pulmonary Haemorrhage 1.8%
Renal Failure 1.8%
Ventricular Tachycardia 1.8%
Cardiac Arrest 1.2%
Cardiac Tamponade 1.2%
Secondary
Product Used For Unknown Indication 39.1%
Acute Coronary Syndrome 17.2%
Angina Unstable 12.1%
Acute Myocardial Infarction 8.8%
Cerebrovascular Accident 5.6%
Coronary Angioplasty 2.8%
Infarction 2.8%
Angina Pectoris 1.9%
Chest Pain 1.9%
Drug Use For Unknown Indication 1.4%
Arteriogram Coronary 0.9%
Diabetes Mellitus 0.9%
Rheumatoid Arthritis 0.9%
Thrombolysis 0.9%
Angiogram 0.5%
Asthma 0.5%
Cardiac Enzymes Increased 0.5%
Electrocardiogram St Segment Depression 0.5%
Pain 0.5%
Prophylaxis 0.5%
Thrombocytopenia 15.2%
Troponin I Increased 9.1%
Cerebral Haemorrhage 6.1%
Haematoma 6.1%
Renal Failure 6.1%
Respiratory Tract Haemorrhage 6.1%
Shock 6.1%
Thrombosis 6.1%
Vomiting 6.1%
Brain Stem Infarction 3.0%
Electrocardiogram St Segment Depression 3.0%
Electromechanical Dissociation 3.0%
Haematuria 3.0%
Myocardial Infarction 3.0%
Off Label Use 3.0%
Pulmonary Embolism 3.0%
Rales 3.0%
Sepsis 3.0%
Septic Shock 3.0%
Toxicity To Various Agents 3.0%
Concomitant
Product Used For Unknown Indication 37.3%
Drug Use For Unknown Indication 18.6%
Coronary Artery Bypass 6.8%
Acute Coronary Syndrome 5.6%
Hypertension 5.6%
Percutaneous Coronary Intervention 3.1%
Stent Placement 3.1%
Anticoagulant Therapy 2.5%
Blood Cholesterol Increased 2.5%
Catheterisation Cardiac 2.5%
Contraception 2.5%
Angina Unstable 1.9%
Acute Myocardial Infarction 1.2%
Chest Pain 1.2%
Coronary Arterial Stent Insertion 1.2%
Hypotension 1.2%
Musculoskeletal Pain 1.2%
Actinic Keratosis 0.6%
Coronary Artery Disease 0.6%
Ill-defined Disorder 0.6%
Anxiety 9.4%
Thrombosis In Device 9.4%
Catheter Related Complication 6.3%
Death 6.3%
Emotional Distress 6.3%
Fear 6.3%
Gallbladder Injury 6.3%
Myocardial Infarction 6.3%
Thrombosis 6.3%
Vomiting 6.3%
Anhedonia 3.1%
Cerebellar Haemorrhage 3.1%
Coronary Artery Thrombosis 3.1%
Device Occlusion 3.1%
Disability 3.1%
Injury 3.1%
Pericardial Effusion 3.1%
Post Procedural Complication 3.1%
Pulmonary Haemorrhage 3.1%
Renal Injury 3.1%
Interacting
Acute Coronary Syndrome 100.0%
Thrombocytopenia 100.0%